Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05362344 · ClinicalTrials.gov registry record
Colorectal Cancer Screening in Cystic Fibrosis
A clinical trial of Colorectal Cancer and Cystic Fibrosis, sponsored by University of Washington, the Collaborative Health Studies Coordinating Center.
- Active
- Registry status
- 350
- Enrollment target
- 20
- Study locations
NCT05362344: Active study of Colorectal Cancer and Cystic Fibrosis, sponsored by University of Washington, the Collaborative Health Studies Coordinating Center.
NCT05362344 is a study of Colorectal Cancer and Cystic Fibrosis that is active but no longer recruiting, run by University of Washington, the Collaborative Health Studies Coordinating Center. The registered enrollment target is 350 participants, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (77% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05362344, a study of Colorectal Cancer and Cystic Fibrosis, is active but no longer recruiting, sponsored by University of Washington, the Collaborative Health Studies Coordinating Center.
- ACTIVE NOT RECRUITING
- Registry status
- 350 participants
- Enrollment target
- 20
- Study locations
Study Summary
This multi-center study will compare multi-target DNA and quantitative FIT stool-based testing to colonoscopy in individuals with Cystic Fibrosis (CF) undergoing colon cancer screening with colonoscopy. The primary endpoint is detection of any adenomas, including advanced adenomas and colorectal cancer (CRC).
Primary Outcome
Negative predictive value (NPV) and sensitivity for detection of any adenomas, advanced adenomas, and CRC in stool-based testing.
Conditions Studied
Interventions
- PROCEDURE Stool tests
Study Locations (20)
California
- University of California, Los Angeles - Los Angeles
- Stanford University Medical Center - Palo Alto
Massachusetts
- Massachusetts General Hospital - Boston
- Boston Children's Hospital - Boston
Missouri
- Saint Louis University - St Louis
- Washington University - St Louis
North Carolina
- North Carolina Children's Hospital / UNC - Chapel Hill
- Atrium Health Pulmonary Care - Charlotte
Ohio
- University Hospitals Rainbow Babies & Children's - Cleveland
- Nationwide Children's Hospital - Columbus
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Colorado
- National Jewish Health, University of Colorado - Denver
Florida
- University of Miami Hospital - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2026-06-30 |
Sponsor
University of Washington, the Collaborative Health Studies Coordinating Center5 total trials
What the registry record for NCT05362344 still lists
NCT05362344 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (77% lower).
The record links to 3 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Stool tests is the first listed.
NCT05362344 names 20 study sites across 14 states, led by California, Massachusetts, Missouri.
Frequently Asked Questions
What is clinical trial NCT05362344 about?
NCT05362344 is a clinical study titled "Colorectal Cancer Screening in Cystic Fibrosis". This multi-center study will compare multi-target DNA and quantitative FIT stool-based testing to colonoscopy in individuals with Cystic Fibrosis (CF) undergoing colon cancer screening with colonoscopy. The primary endpoint is detection of any adenomas, including advanced adenomas and colorectal can...
What is the current status of trial NCT05362344?
This trial is currently active not recruiting. The enrollment target is 350 participants. The study started on 2022-09-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05362344 study?
This clinical trial studies the following conditions: Colorectal Cancer, Cystic Fibrosis, Adenoma.
What interventions are being tested in trial NCT05362344?
The interventions under investigation include: Stool tests (PROCEDURE).
Who is sponsoring clinical trial NCT05362344?
This trial is sponsored by University of Washington, the Collaborative Health Studies Coordinating Center, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05362344 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Kansas, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05362344's enrollment target sits among peer trials
350 101st of 381 higher than 281 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI